Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank Ghantoji

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Outcomes associated with pharmacotherapy in overactive bladderMonali J Bhosle, Samuel Wagner, Shashank Ghantoji, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2010
A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infectionKevin W Garey, Zhi-Dong Jiang, Shashank Ghantoji, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant RecipientsFarnaz Foolad, Samuel L Aitken, Terri Lynn Shigle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Effectiveness and Safety of Retreatment with <sup>177</sup>Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United StatesEbrahim S Delpassand, Soheil M Yazdi, Shashank Ghantoji, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Outcomes associated with pharmacotherapy in overactive bladderMonali J Bhosle, Samuel Wagner, Shashank Ghantoji, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 10, 2010
A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infectionKevin W Garey, Zhi-Dong Jiang, Shashank Ghantoji, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant RecipientsFarnaz Foolad, Samuel L Aitken, Terri Lynn Shigle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Effectiveness and Safety of Retreatment with <sup>177</sup>Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United StatesEbrahim S Delpassand, Soheil M Yazdi, Shashank Ghantoji, et al.
Pageof 1